The impact of the 2020 COVID-19-related suspension of BreastScreen NSW on breast cancer tumour size and treatment
Public Health Res Pract
.
2023 Sep 13;33(3):32342217.
doi: 10.17061/phrp32342217.
Authors
Amanda A Jayakody
1
,
Kan Ren
2
,
Richard J Walton
2
,
Matthew E Warner-Smith
2
,
Nicola Scott
2
,
Anthea M Temple
2
,
Chirag Mistry
2
,
Sarah J McGill
2
Affiliations
1
Cancer Institute NSW, Sydney, Australia; amanda.jayakody@health.nsw.gov.au.
2
Cancer Institute NSW, Sydney, Australia.
PMID:
36477979
DOI:
10.17061/phrp32342217
No abstract available
MeSH terms
Breast Neoplasms*
COVID-19*
Early Detection of Cancer
Female
Humans
Mass Screening